Immatics N.V. Warrants

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch IMTXW and buy or sell other stocks, ETFs, and their options commission-free!

About IMTXW

Immatics NV is a clinical stage biopharmaceutical company, which engages in the research and development of T cell receptor-based immunotherapies for the treatment of cancer. Its pipeline includes adoptive cell therapy and TCR Bispecifics. 

CEO
Harpreet Singh-Jasuja, PhD
CEOHarpreet Singh-Jasuja, PhD
Employees
Employees
Headquarters
Tuebingen, Baden Wuerttemberg
HeadquartersTuebingen, Baden Wuerttemberg
Founded
2020
Founded2020
Employees
Employees

IMTXW Key Statistics

Market cap
Market cap
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
35.19K
Average volume35.19K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$3.45
52 Week high$3.45
52 Week low
$0.0006
52 Week low$0.0006
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.